電気薬学・生体電気医療の市場規模・シェア・成長分析 (製品種類別、デバイスの種類別、用途別、エンドユーザー別、地域別)：産業予測 (2025～2032年)

世界の電気薬学 (Electroceuticals)・生体電気医療 (Bioelectric Medicine) の市場規模は、2023年に239億米ドルと評価され、2024年の253億6,000万米ドルから2032年には407億2,000万米ドルに成長し、予測期間 (2025-2032年) のCAGRは6.1%に達する見通しです。

生体電子医療 (bioelectronic medicine) の市場は、慢性疾患や急性疾患の罹患率の上昇、高齢化、主要企業による進歩など、いくつかの重要な要因によって大きな成長が見込まれています。注目すべき取り組みとしては、2022年1月に生体電子医療推進連盟が「生体電子医療の日」を立ち上げ、この分野の重要性を強調したことが挙げられます。生体工学、分子医学、神経学を融合させた電気薬学装置は、慢性疾患、特に米国で年間61万人以上の命を奪っている心血管疾患の治療において、ますます重要性を増しています。研究開発への多額の投資と新技術に対する規制上の承認は、市場の潜在力を高め続けているが、厳しい政府規制と潜在的な製品回収が課題となっています。これらの要因が重なることで、市場情勢は急速に進化・拡大しています。

目次

イントロダクション

• 分析目的
• 市場範囲
• 定義

分析手法

• 情報調達
• 二次・一次データの手法
• 市場規模予測
• 市場の想定と制約

エグゼクティブサマリー

• 市場の概要と展望
• 需給動向の分析
• セグメント別の機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析

市場の主な考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場魅力度指数 (2024年)
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術分析
• 規制分析
• 特許分析
• ケーススタディ

世界の電気薬学・生体電気医療の市場規模・CAGR：製品別 (2025～2032年)

• 市場概要
• 心臓ペースメーカー・植込み型除細動器 (ICD)
• 人工内耳
• 脊髄刺激装置
• 脳深部刺激装置
• 迷走神経刺激装置
• 仙骨神経刺激装置
• その他

世界の電気薬学・生体電気医療の市場規模・CAGR：デバイスの種類別 (2025～2032年)

• 市場概要
• 埋め込み型デバイス
• 非侵襲性デバイス

世界の電気薬学・生体電気医療の市場規模・CAGR：用途別 (2025～2032年)

• 市場概要
• 不整脈
• 感音難聴
• てんかん
• パーキンソン病
• その他

世界の電気薬学・生体電気医療の市場規模・CAGR：エンドユーザー別 (2025～2032年)

• 市場概要
• 病院
• 外来手術センター
• その他

世界の電気薬学・生体電気医療の市場規模・CAGR (2025～2032年)

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング (2024年)
• 主要企業が採用した戦略
• 市場の近年の動向
• 主要企業の市場シェア (2024年)
• 主要企業のプロファイル
  • 企業概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較 (2022～2024年)

主要企業のプロファイル

• Medtronic (アイルランド)
• Abbott (米国)
• Boston Scientific Corporation (米国)
• Cochlear Ltd. (オーストラリア)
• LivaNova PLC (英国)
• Biotronik SE & Co. KG (ドイツ)
• electroCore, Inc. (米国)
• Sonova (スイス)
• Nevro Corp. (米国)
• Stimwave LLC (米国)
• SetPoint Medical (米国)
• Sky Medical Technology (英国)
• Cala Health (米国)
• NeuroPace, Inc. (米国)
• Koninklijke Philips N.V. (オランダ)
• WEINMANN Emergency Medical Technology GmbH+Co. KG (ドイツ)
• Sonova Holding AG (スイス)
• Oticon Medical AB (デンマーク)
• BioElectronics Corporation (米国)
• MicroTransponder Inc. (米国)

結論と推奨事項

Global Electroceuticals Bioelectric Medicine Market size was valued at USD 23.9 billion in 2023 and is poised to grow from USD 25.36 billion in 2024 to USD 40.72 billion by 2032, growing at a CAGR of 6.1% during the forecast period (2025-2032).

The bioelectronic medicine market is poised for significant growth, driven by several key factors, including the rising incidence of chronic and acute diseases, an aging population, and advancements made by leading companies. A notable initiative was the launch of Bioelectronic Medicine Day by the Alliance for Advancing Bioelectronic Medicine in January 2022, highlighting the importance of this field. Electroceutical devices that blend bioengineering, molecular medicine, and neurology are increasingly relevant in treating chronic conditions, particularly cardiovascular diseases, which claim over 610,000 lives annually in the U.S. Significant investments in R&D and regulatory approvals for new technologies continue to enhance market potential, though strict government regulations and potential product recalls pose challenges. The convergence of these factors suggests a rapidly evolving and expanding market landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Electroceuticals Bioelectric Medicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Electroceuticals Bioelectric Medicine Market Segmental Analysis

Global Electroceuticals Bioelectric Medicine Market is segmented by Product, Device Type, Application, End User and region. Based on Product, the market is segmented into Cardiac Pacemakers and Implantable Cardioverter Defibrillators, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators and Others. Based on Device Type, the market is segmented into Implantable Devices and Non-invasive Devices. Based on Application, the market is segmented into Arrhythmia, Sensorineural Hearing Loss, Epilepsy, Parkinson's Disease and Others. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Electroceuticals Bioelectric Medicine Market

The global Electroceuticals Bioelectric Medicine market is primarily driven by the increasing prevalence of neurological and cardiovascular complications among the aging population, which requires innovative medical solutions. As this demographic grows, it fuels the demand for electroceutical devices such as cardiac pacemakers, implantable cardioverter defibrillators, deep brain stimulators, and spinal cord stimulators. Emerging economies, particularly in regions like South Korea, Malaysia, Vietnam, Africa, Israel, Saudi Arabia, and the UAE, present significant growth opportunities for major market players due to their favorable regulatory environments and improving healthcare infrastructures. The expanding patient base and rising healthcare costs further enhance the market's potential, prompting companies to focus on these emerging markets while facing intensified competition in more developed regions.

Restraints in the Global Electroceuticals Bioelectric Medicine Market

The growth of the Global Electroceuticals Bioelectric Medicine market is significantly hampered by the high costs associated with electroceutical devices, such as cochlear implants and neurostimulators, particularly in price-sensitive regions like Asia Pacific, Latin America, and Africa. Many healthcare providers in developing nations, such as Brazil and Mexico, lack the necessary financial resources to invest in advanced technologies. Furthermore, effective deployment of these devices requires extensive training for personnel, adding another layer of difficulty. The need for significant research and development to produce innovative electroceutical products increases manufacturing costs. Additionally, the shortage of skilled professionals, including neurologists and neurosurgeons, further restricts the availability of neurosurgical procedures, negatively impacting market demand for devices like neurostimulators.

Market Trends of the Global Electroceuticals Bioelectric Medicine Market

The Global Electroceuticals Bioelectric Medicine market is witnessing significant growth driven by the increasing acceptance of advanced medical devices such as defibrillators and pacemakers. Technological advancements, exemplified by Abbott Laboratories' FDA-approved Gallant line featuring Bluetooth-integrated implantable cardioverter-defibrillators, are expanding the market's capabilities. The introduction of modern pacemakers equipped with data recording, safe MRI compatibility, and remote monitoring functionalities further stimulates demand. As healthcare providers and patients increasingly recognize the benefits of these innovative therapies, the market is poised for robust expansion, enhancing patient outcomes and driving investments in this burgeoning field of bioelectric medicine.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Case Studies

Global Electroceuticals Bioelectric Medicine Market Size by Product & CAGR (2025-2032)

• Market Overview
• Cardiac Pacemakers and Implantable Cardioverter Defibrillators
• Cochlear Implants
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Vagus Nerve Stimulators
• Sacral Nerve Stimulators
• Others

Global Electroceuticals Bioelectric Medicine Market Size by Device Type & CAGR (2025-2032)

• Market Overview
• Implantable Devices
• Non-invasive Devices

Global Electroceuticals Bioelectric Medicine Market Size by Application & CAGR (2025-2032)

• Market Overview
• Arrhythmia
• Sensorineural Hearing Loss
• Epilepsy
• Parkinson's Disease
• Others

Global Electroceuticals Bioelectric Medicine Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Others

Global Electroceuticals Bioelectric Medicine Market Size & CAGR (2025-2032)

• North America (Product, Device Type, Application, End User)
  • US
  • Canada
• Europe (Product, Device Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Device Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Device Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Device Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cochlear Ltd. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• electroCore, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sonova (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corp. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stimwave LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SetPoint Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sky Medical Technology (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cala Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WEINMANN Emergency Medical Technology GmbH + Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sonova Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oticon Medical AB (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioElectronics Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroTransponder Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations